<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04789889</url>
  </required_header>
  <id_info>
    <org_study_id>JTU-6H-20210227001</org_study_id>
    <nct_id>NCT04789889</nct_id>
  </id_info>
  <brief_title>Comparison Between IORT and Postoperative Radiotherapy in Breast Conserving Surgery</brief_title>
  <official_title>Comparison of Satisfaction With Conserved Breast, Postoperative Complications and Tumor Control Between IORT and Postoperative Radiotherapy in Breast Conserving Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiangyun Zong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the satisfaction with conserved breast, acute and chronic postoperative&#xD;
      complications and tumor control between intraoperative radiotherapy(IORT) and traditional&#xD;
      postoperative radiotherapy following breast-conserving surgery (BCS).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2025</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of successful surgical procedure</measure>
    <time_frame>immediately after surgery</time_frame>
    <description>the rate of successful breast conserving surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>satisfaction with conserved breast</measure>
    <time_frame>1 month after surgery</time_frame>
    <description>the patients' satisfaction to postoperative breast including shape and feeling(Harvard/NSABP/RTOG BREAST COSMETIC SCALE: excellent, good, fair, poor)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of acute and chronic postoperative complications（CTCAE 3.0)</measure>
    <time_frame>1-month, 6-month after surgery</time_frame>
    <description>The incidence of adverse reactions at 1 and 6 months after operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DFS</measure>
    <time_frame>2-3 years after surgery</time_frame>
    <description>long-term postoperative disease-free survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OS</measure>
    <time_frame>2-3 years after surgery</time_frame>
    <description>long-term postoperative overall survival</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>IORT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intraoperative radiotherapy(IORT) in BCS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PORT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>traditional postoperative radiotherapy following BCS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>intraoperative radiotherapy</intervention_name>
    <description>intraoperative radiotherapy</description>
    <arm_group_label>IORT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>postoperative radiotherapy</intervention_name>
    <description>postoperative radiotherapy</description>
    <arm_group_label>PORT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primary invasive breast cancer confirmed by pathology.&#xD;
&#xD;
          -  Maximum tumor diameter ≤3.5cm.&#xD;
&#xD;
          -  Clinical lymph nodes are negative.&#xD;
&#xD;
          -  Single or multiple tumors are located on the same side of the nipple and in the same&#xD;
             quadrant.&#xD;
&#xD;
          -  ECOG status score ≤ 2.&#xD;
&#xD;
          -  With informed Consents.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous history of breast cancer or other malignant tumors.&#xD;
&#xD;
          -  Inflammatory breast cancer; 3. Previous radiotherapy history.&#xD;
&#xD;
          -  Other diseases affecting radiotherapy, such as connective tissue disease, heart&#xD;
             disease, lung disease and so on.&#xD;
&#xD;
          -  Patients who are not going to have the axillary lymph node surgery (including SLN and&#xD;
             ALND) were excluded.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ZONG, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Shanghai Jiao Tong University affiliated 6th Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200233</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Kawamura M, Itoh Y, Kamomae T, Sawaki M, Kikumori T, Tsunoda N, Ito J, Shimoyama Y, Satake H, Naganawa S. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 10-year results with critical evaluation. J Radiat Res. 2020 Jul 6;61(4):602-607. doi: 10.1093/jrr/rraa029.</citation>
    <PMID>32494808</PMID>
  </reference>
  <reference>
    <citation>Wang L, Zhu M, Cui Y, Zhang X, Li G. Efficacy analysis of intraoperative radiotherapy in patients with early-stage breast cancer. Cancer Cell Int. 2020 Sep 11;20:446. doi: 10.1186/s12935-020-01533-z. eCollection 2020.</citation>
    <PMID>32943994</PMID>
  </reference>
  <reference>
    <citation>Forster T, Jäkel C, Akbaba S, Krug D, Krempien R, Uhl M, Häfner MF, König L, Koerber SA, Harrabi S, Bernhardt D, Behnisch R, Krisam J, Hennigs A, Sohn C, Heil J, Debus J, Hörner-Rieber J. Fatigue following radiotherapy of low-risk early breast cancer - a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419). Radiat Oncol. 2020 Jun 1;15(1):134. doi: 10.1186/s13014-020-01581-9.</citation>
    <PMID>32487184</PMID>
  </reference>
  <reference>
    <citation>Hu X, He Y, Chen X, Xia T, Cao T, Jia H, Zhang L. Impact of intraoperative radiotherapy on the perioperative period of patients after breast-conserving surgery. Gland Surg. 2020 Oct;9(5):1535-1542. doi: 10.21037/gs-20-727.</citation>
    <PMID>33224829</PMID>
  </reference>
  <reference>
    <citation>Gondim GRM, Makdissi FBA, Fogaroli RC, Collins JBD, Iyeyasu H, de Castro DG, Silva MLG, Chen MJ, Coelho TM, Ramos H, Pellizzon ACA. Intraoperative breast radiotherapy: survival, local control and risk factors for recurrence. Rep Pract Oncol Radiother. 2019 Nov-Dec;24(6):551-555. doi: 10.1016/j.rpor.2019.09.004. Epub 2019 Oct 16.</citation>
    <PMID>31660047</PMID>
  </reference>
  <reference>
    <citation>Uhlig S, Wuhrer A, Berlit S, Tuschy B, Sütterlin M, Bieback K. Intraoperative radiotherapy for breast cancer treatment efficiently targets the tumor bed preventing breast adipose stromal cell outgrowth. Strahlenther Onkol. 2020 Apr;196(4):398-404. doi: 10.1007/s00066-020-01586-z. Epub 2020 Feb 6.</citation>
    <PMID>32030446</PMID>
  </reference>
  <reference>
    <citation>Sasieni PD, Sawyer EJ. Intraoperative radiotherapy for early breast cancer - insufficient evidence to change practice. Nat Rev Clin Oncol. 2020 Dec;17(12):723-724. doi: 10.1038/s41571-020-00444-2.</citation>
    <PMID>33087894</PMID>
  </reference>
  <reference>
    <citation>Vaidya JS, Bulsara M, Baum M, Alvarado M, Bernstein M, Massarut S, Saunders C, Sperk E, Wenz F, Tobias JS; TARGIT-A investigators. Intraoperative radiotherapy for breast cancer: powerful evidence to change practice. Nat Rev Clin Oncol. 2021 Mar;18(3):187-188. doi: 10.1038/s41571-021-00471-7.</citation>
    <PMID>33495552</PMID>
  </reference>
  <reference>
    <citation>Vaidya JS, Bulsara M, Baum M, Wenz F, Massarut S, Pigorsch S, Alvarado M, Douek M, Saunders C, Flyger HL, Eiermann W, Brew-Graves C, Williams NR, Potyka I, Roberts N, Bernstein M, Brown D, Sperk E, Laws S, Sütterlin M, Corica T, Lundgren S, Holmes D, Vinante L, Bozza F, Pazos M, Le Blanc-Onfroy M, Gruber G, Polkowski W, Dedes KJ, Niewald M, Blohmer J, McCready D, Hoefer R, Kelemen P, Petralia G, Falzon M, Joseph DJ, Tobias JS. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial. BMJ. 2020 Aug 19;370:m2836. doi: 10.1136/bmj.m2836.</citation>
    <PMID>32816842</PMID>
  </reference>
  <reference>
    <citation>Onthong K, Chakkabat C, Nantavithya C, Shotelersuk K, Denariyakoon S, Vongsaisuwon M, Chulakadabbav A, Chatamra K, Saksornchai K. Results of intraoperative radiotherapy given as a boost after breast conserving-surgery. Gland Surg. 2020 Oct;9(5):1389-1395. doi: 10.21037/gs-20-249.</citation>
    <PMID>33224814</PMID>
  </reference>
  <reference>
    <citation>Vaidya JS, Bulsara M, Baum M, Tobias JS; TARGIT-A trial authors. Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment. Br J Cancer. 2021 Apr;124(9):1469-1474. doi: 10.1038/s41416-020-01233-5. Epub 2021 Feb 2.</citation>
    <PMID>33531693</PMID>
  </reference>
  <reference>
    <citation>Feng K, Meng X, Liu J, Xing Z, Zhang M, Wang X, Feng Q, Wang X. Update on intraoperative radiotherapy for early-stage breast cancer. Am J Cancer Res. 2020 Jul 1;10(7):2032-2042. eCollection 2020. Review.</citation>
    <PMID>32774999</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>March 2, 2021</study_first_submitted>
  <study_first_submitted_qc>March 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2021</study_first_posted>
  <last_update_submitted>November 4, 2021</last_update_submitted>
  <last_update_submitted_qc>November 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</investigator_affiliation>
    <investigator_full_name>Xiangyun Zong</investigator_full_name>
    <investigator_title>Director of Breast Cancer</investigator_title>
  </responsible_party>
  <keyword>intraoperative radiotherapy</keyword>
  <keyword>breast-conserving surgery</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

